Sandler Alan B. — SEC Form 4 filings
SEC reporting owner CIK 1835966. 10 Form 4 filings on record with FilingPulse; latest filed 2026-09-18.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-01-23 to 2026-09-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 1 filing — 341 shares, $67,941 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 14.
- Largest priced transaction: sale of 336 shares @ $199.30 ($66,966) in Revolution Medicines, Inc., filed 2026-09-18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | Chief Development Officer | 1 | — | 2 legs · 341 sh · $67,941 | — |
| Elevation Oncology, Inc. (ELEV) | Director | 4 | — | — | 6 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | Director | 4 | — | — | 4 |
| Mirati Therapeutics, Inc. (MRTX) | Chief Medical Officer | 1 | — | — | 4 |
Form 4 filings — Sandler Alan B.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-18 | 4 | Revolution Medicines, Inc. (RVMD) | Sale (S): 5 @ $194.96 · Sale (S): 336 @ $199.30 | EDGAR |
| 2026-01-21 | 4 | ALX ONCOLOGY HOLDINGS INC (ALXO) | Grant/award (A): 10,100 (derivative) @ $0 | EDGAR |
| 2025-07-24 | 4 | Elevation Oncology, Inc. (ELEV) | Disposition to issuer (D): 55,000 (derivative) @ $0 · Disposition to issuer (D): 35,000 (derivative) @ $0 · Disposition to issuer (D): 35,000 (derivative) @ $0 | EDGAR |
| 2025-06-09 | 4 | Elevation Oncology, Inc. (ELEV) | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2025-04-15 | 4 | ALX ONCOLOGY HOLDINGS INC (ALXO) | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2024-11-19 | 4 | ALX ONCOLOGY HOLDINGS INC (ALXO) | Grant/award (A): 600,000 (derivative) @ $0 | EDGAR |
| 2024-08-07 | 4 | ALX ONCOLOGY HOLDINGS INC (ALXO) | Grant/award (A): 40,400 (derivative) @ $0 | EDGAR |
| 2024-06-17 | 4 | Elevation Oncology, Inc. (ELEV) | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2024-03-04 | 4 | Elevation Oncology, Inc. (ELEV) | Grant/award (A): 55,000 (derivative) @ $0 | EDGAR |
| 2024-01-23 | 4 | Mirati Therapeutics, Inc. (MRTX) | Disposition to issuer (D): 10,547 · Disposition to issuer (D): 52,297 · Disposition to issuer (D): 17,021 · Disposition to issuer (D): 65,000 (derivative) | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1835966 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →